Key result
Circulating miR-149, miR-424, and miR-765 accurately identify CAD with AUCs up to ~0.98.
Why the study?
Circulating microRNAs are recognized as promising biomarkers for various diseases, and the potential roles of circulating miR-149, miR-424, and miR-765 as non-invasive diagnostic biomarkers for coronary artery disease in middle-aged (40-60-year-old) patients needed to be explored.
Do circulating plasma levels of miR-149, miR-424, and miR-765 accurately diagnose coronary artery disease in middle-aged (40-60-year-old) patients compared with matched non-CAD controls?
Case-Control (n=127)
No
Do circulating plasma levels of miR-149, miR-424, and miR-765 accurately diagnose coronary artery disease in middle-aged (40-60-year-old) patients compared with matched non-CAD controls?
Answers are grounded in this paper and cite their sources.
Circulating plasma miR-149, miR-424, and miR-765 demonstrated high diagnostic accuracy (AUCs 0.919-0.977) as potential non-invasive biomarkers for identifying stable and unstable coronary artery disease in middle-aged patients.
OBJECTIVE: Circulating microRNAs have been recognized as promising biomarkers for various diseases. The present study aimed to explore the potential roles of circulating miR-149, miR-424 and miR-765 as non-invasive biomarkers for the diagnosis of coronary artery disease in middle-aged (40-60-year-old) patients. METHODS: Sixty-five stable coronary artery disease patients (49-57 years old), 30 unstable coronary artery disease patients (49-58 years old), and 32 non-coronary artery disease patients (49--57 years old) who were matched for age, sex, smoking habits, hypertension and diabetes were enrolled in this study. Total RNA was isolated from plasma with TRIzol reagent. Circulating miRNA levels were measured by quantitative real-time polymerase chain reaction. RESULTS: Circulating miR-149 levels were decreased 4.49-fold in stable coronary artery disease patients (1.18 ± 0.84) and 5.09-fold in unstable coronary artery disease patients (1.04 ± 0.65) compared with non-coronary artery disease patients (5.30 ± 2.57) (p<0.001). Circulating miR-424 levels were reduced 3.6-fold in stable coronary artery disease patients (1.18 ± 0.60) and 5-fold in unstable coronary artery disease patients (0.86 ± 0.54) compared with non-coronary artery disease patients (4.35 ± 2.20) (p<0.001). In contrast, circulating miR-765 levels were elevated 3.98-fold in stable coronary artery disease patients (6.09 ± 2.27) and 5.33-fold in unstable coronary artery disease patients (8.17 ± 2.77) compared with non-coronary artery disease patients (1.53 ± 0.99) (p<0.001). Receiver operating characteristic curve analysis revealed that the respective areas under the curve for circulating miR-149, miR-424 and miR-765 were 0.938, 0.919 and 0.968 in stable CAD patients and 0.951, 0.960 and 0.977 in unstable coronary artery disease patients compared with non-coronary artery disease patients. CONCLUSION: Our results suggest that circulating miR-149, miR-424 and miR-765 might be novel, non-invasive biomarkers for the diagnosis of coronary artery disease in middle-aged patients. However, future prospective trials in large patient cohorts are necessary before reaching a solid conclusion.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2015) conducted a case-control in Coronary artery disease (CAD) (n=127). Circulating plasma microRNAs (miR-149, miR-424, and miR-765) vs. Non-coronary artery disease patients (n=32) matched for age, sex, smoking habits, hypertension, and diabetes was evaluated on Diagnostic accuracy (ROC AUC) and plasma expression levels of circulating miR-149, miR-424, and miR-765 for CAD (p=<0.001). Circulating miR-149, miR-424, and miR-765 discriminated stable and unstable CAD from non-CAD in middle-aged patients with ROC AUCs of 0.919 to 0.977.
Synapse has enriched 10 related papers. Consider them for comparative context: